Clinical Trial Update: Assessment of Current Biomarker Testing Practices for Common Solid Cancers in Precision Oncology in the Community Setting

View source ↗

Summary

The ECOG-ACRIN trial assessing biomarker testing practices for common solid cancers in community oncology settings has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Melanoma

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Breast Carcinoma, Colorectal Carcinoma | Status: WITHDRAWN